The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

Topical roflumilast 0.3% cream has been approved by the FDA to treat plaque psoriasis in patients 12 years and older since ...

Treating psoriasis, a chronic inflammatory skin condition characterized by thick, scaly, red patches that can be itchy and painful, can be challenging if it appears on both the body and the scalp.

Let’s discuss four foods to avoid with psoriasis that may be affecting your skin, along with healthier substitutes.

“Interesting, the main thing that is often perceived as dandruff is caused by not washing the hair sufficiently or frequently ...

A new King’s College London study links abdominal fat—not general obesity—to increased psoriasis risk, especially in women, ...

Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.

Starjemza (ustekinumab-hmny) was approved by the FDA this week as a biosimilar to Stelara. 2 A pair of clinical trials ...

New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, ...